Stratum Biosciences

Stratum Biosciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://stratumbio.com/

Last Round

Seed

Mar 27, 2026

Total Funding Raised

$2M

Momentum Score

75 /100

Company Overview

Stratum Biosciences is a biotechnology company that operates an AI-powered skin biology discovery platform to develop novel active ingredients and formulations for cosmetic and pharmaceutical skin products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

AI discovery platformingredient discoveryhuman skin biobanknovel active ingredientsskincare R&Ddermatology AIbeauty techtech bioformulation developmentbiomarker discoveryAI drug discoverycosmetic ingredientsR&D partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratum Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Stratum Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMar 27, 2026

Key People

Founding team and executive leadership

Ross Lane Pearlman

Chief Executive Officer, Co-Founder

Founding Team

Stratum Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 63% QoQ, from 8 to 13 employees.

  • Apr 21, 2026

    Monthly visitors increased 62% MoM.

Stratum Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stratum Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stratum Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range13
Year Founded2024
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.